Maksansiirdamine

Maksansiirdamine is the surgical procedure to replace a diseased or damaged liver with a healthy liver from a donor. This life-saving operation is typically performed when a patient's liver is failing due to conditions such as cirrhosis, hepatitis, liver cancer, or genetic disorders. The process involves carefully removing the diseased liver and connecting the donor liver to the patient's blood vessels and bile ducts.

There are two main types of liver transplants: deceased donor transplants, where the liver comes from someone who has recently died, and living donor transplants, where a portion of a healthy liver is taken from a living donor, usually a family member or close friend. Living donor transplants are often performed for children or when a suitable deceased donor is not immediately available.

The success rates for liver transplantation have improved significantly over the years, thanks to advancements in surgical techniques, immunosuppressive medications, and post-operative care. Patients undergoing a transplant require lifelong immunosuppressive therapy to prevent their body from rejecting the new organ. Regular monitoring and follow-up care are crucial to manage the health of the transplanted liver and the patient's overall well-being. Despite the risks and challenges, liver transplantation offers a chance for a significantly improved quality of life and survival for individuals with end-stage liver disease.